Nevro Reaffirms FY24 Revenue Guidance Of $435M-$445M (Est $441.038M), Sees Q2 Revenue Of $106M-$108M (Est $111.244M)
Nevro is raising its adjusted EBITDA guidance for the full-year 2024 to a range of negative $5 million to positive $2 million from its previous guidance range of negative $14 million to negative $8 million.
For the second quarter of 2024, the company expects worldwide revenue to be in the range of approximately $106 million to $108 million and adjusted EBITDA to be in the range of negative $3.5 million to negative $2.5 million.